Skip to main content
. 2021 Nov 25;12:777483. doi: 10.3389/fneur.2021.777483

Figure 1.

Figure 1

Mechanism of hypercoagulable state in malignant tumors. Tumor cells activate cellular systems in vivo through intercellular interactions and injured endothelial cells. Tumor cells can directly release tissue factor (TF) and cancer procoaparticles (CP). Tumor cells produce cytokines including interleukin-1 (IL-1) and tumor necrosis factor (TNF). Activated blood cells (such as monocytes and platelets) and the microparticles (MP) produced by these cells work synergistically to increase TF expression and activate the coagulation system in vivo.